BioNTech valuation
$84.86Change from previous close: −0.47%Absolute change: −$0.40
Valuation
The average price target of 20 analysts is $112.40.
Data as of November 17, 2026
BioNTech compared with similar companies
BioNTech's Price/book: 1.07, −87% against the median of a group of 10 similar companies (8.03).
| Metric | BioNTech | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| Price/book | 1.07 | 8.03 | 4.77 – 14.3 | Low |
| Price/sales | 8.77 | 8.14 | 4.95 – 15.9 | Middle |
| Gross margin | 76.7% | 77.3% | 66.1% – 91.5% | Middle |
| Operating margin | -55.4% | 19.5% | -48.6% – 31.6% | Low |
| Net margin | -60.9% | 4.4% | -19.9% – 30.2% | Low |
| ROE | -8.1% | 7.8% | -8.3% – 88.3% | Middle |
| Debt/equity | 0.02 | 0.30 | 0.02 – 0.92 | Low |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Other metrics
Valuation multiples
- Market cap
- $21.22B
- Enterprise value
- $7.75B
- P/E (trailing 12 months)
- -11.5
- Forward P/E
- -16.1
- PEG
- 0.05
- EV/EBITDA
- -7.62
- EV/revenue
- 3.20
Profitability and growth
- ROA
- -4.0%
- ROIC
- -6.2%
- Revenue growth (year over year)
- -15.1%
- Earnings growth (year over year)
- 102.5%
Financial health
- Total cash
- $13.7B
- Total debt
- $359.8M
- Current ratio
- 8.55
- Quick ratio
- 7.91
- Altman Z-Score
- 7.02
- Piotroski F-Score
- 2.00
Dividends
- Payout ratio
- 0.0%
- Ex-dividend date
- June 2, 2022
Analysts and estimates
- Average price target
- $112.40
- Median price target
- $108.59
- High price target
- $144.39
- Low price target
- $74.68
- Analysts with a price target
- 20
- Consensus
- Buy
- Forward EPS
- -$5.31
- EPS estimate, current year
- -$5.09
Shares and trading
- Beta
- 1.33
- Average volume
- 1.24M
- Shares outstanding
- 247.93M
- Float
- 106M
- Institutional ownership
- 20.7%
- Insider ownership
- 57.9%
- Short interest (% of float)
- 3.5%
- Short ratio (days)
- 2.02
